HOt flashes

Paroxetine, Venlafaxine

Both are recommended by the North American Menopause Society as a non-hormonal treatment for hot flashes.

• Paroxetine and venlafaxine are both estrogen and progesterone free
• Paroxetine is shown to decrease the frequency of moderate to severe hot flashes in menopausal women by up to 67 percent
• Venlafaxine (75mg) has been shown to be as effective as a low dose (0.5mg) oral estradiol at reducing the frequency of hot flashes

Available monthly (starting at $35/mo.) and quarterly (starting at $90/3 mo.)

Important safety information

Recommended by the North American Menopause Society

Estrogen and progesterone free

Free 2-day shipping

Free, unlimited follow-ups with a healthcare professional

The science behind paroxetine

Paroxetine, in low doses, has been shown to be an effective and safe non-hormonal treatment for reducing the frequency and severity of hot flashes in menopausal women. Many women are not eligible for systemic hormone therapy, and others are concerned about the risks. Paroxetine is a powerful alternative to systemic estrogen-based medications (hormone replacement therapy). 

The science behind venlafaxine

Venlafaxine has been shown to be an effective and safe non-hormonal treatment for significantly reducing the frequency and severity of hot flashes for menopausal women. Venlafaxine is in the family of medication called serotonin-norepinephrine reuptake inhibitors (SNRIs) and is most commonly used to treat anxiety and depression. However, it is also effective in decreasing the frequency and severity of hot flashes. Prior to non-hormonal treatments for hot flashes, the majority of care options were oral estrogen and progesterone, and now women have the option of effective non-hormonal treatment.

FAQ

Have a question not listed here? Visit our FAQs, or reach out to our care team and we’ll be happy to help. To speak to a care representative, give us a call at (888) 798-8686 or email us at [email protected].